Monalizumab Chemical Properties

storage temp. 

Store at -20°C

Water Solubility 

Soluble in water

Monalizumab Usage And Synthesis

Uses

Monalizumab (IPH2201) is a potentially first-in-class immune checkpoint inhibitor targeting NKG2A receptors expressed on tumor infiltrating cytotoxic CD8+ T cells and NK cells.

Mechanism of action

Monalizumab is a blocking antibody that prevents the inhibition of CD8+ T cells and NK cell by tumor cells expressing HLA-E. By acting simultaneously on innate and adaptive immunity, monalizumab may re-establish a broad anti-tumor response.

Monalizumab(1228763-95-8)Related Product Information

• Durvalumab
• Denosumab
• Evolocumab
• Enfortumab Vedotin
• Avelumab
• Alirocumab
• Nivolumab
• Tislelizumab
• Toripalimab
• Lambrolizumab